Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension
2020
A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma
2020
Indocyanine Green Retention Test as a Noninvasive Marker of Portal Hypertension and Esophageal Varices in Compensated Liver Cirrhosis
2013
Risks versus benefits of gastrointestinal endoscopy during pregnancy
2011
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
2018
Management of patients with hepatitis B who require immunosuppressive therapy
2013
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
The ART Score Is Not Effective to Select Patients for Transarterial Chemoembolization Retreatment in an Italian Series
2014
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
2019
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma
2016
Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”
2012
Artificial intelligence in medical imaging: threat or opportunity? Radiologists again at the forefront of innovation in medicine
2018 Standout
Hepatocellular carcinoma
2021 Standout
Cone-Beam CT Angiography for Determination of Tumor-Feeding Vessels During Chemoembolization of Liver Tumors: Comparison of Conventional and Dedicated-Software Analysis
2015
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Chemoembolization (TACE) of Unresectable Intrahepatic Cholangiocarcinoma with Slow-Release Doxorubicin-Eluting Beads: Preliminary Results
2008
Clinical decision making and research in hepatocellular carcinoma: Pivotal role of imaging techniques
2010
Radiofrequency Ablation of Intrahepatic Cholangiocarcinoma: Preliminary Experience
2010
Radioembolization for hepatocellular carcinoma
2011
Crohn's disease
2016 Standout
Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: Experience of the Bologna Liver Oncology Group
2014
Personalized treatment of patients with very early hepatocellular carcinoma
2016
Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: A radiological-pathological correlation
2012
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Modified RECIST to assess tumor response after transarterial chemoembolization of hepatocellular carcinoma: CT–pathologic correlation in 178 liver explants
2013
The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy
2017
Treatment of intermediate-stage hepatocellular carcinoma
2014
Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients
2015
Hepatocellular carcinoma
2022 Standout
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection
2018
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Local and Regional Therapies for Hepatocellular Carcinoma
2020
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Downstaging of hepatocellular cancer before liver transplant: Long‐term outcome compared to tumors within Milan criteria
2015
Prognostic Value of the Albumin-Bilirubin Grade for the Prediction of Post-Hepatectomy Liver Failure: A Systematic Review and Meta-Analysis
2021
Clinical Practice Guideline for the Surgical Management of Crohn’s Disease
2015
Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation
2014
Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma
2013
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Liver Transplantation and Hepatic Resection can Achieve Cure for Hepatocellular Carcinoma
2018
Review article: optimal preparation for surgery in Crohn's disease
2014
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Works of Alberta Cappelli being referenced
Cost-effectiveness of doxorubicin-eluting beads versus conventional trans-arterial chemo-embolization for hepatocellular carcinoma
2016
A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma
2011
Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substage
2018
Transjugular intrahepatic portosystemic shunt: A case report of rescue management of unrestrainable variceal bleeding in a pregnant woman
2007
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation
2010
CT-guided percutaneous pelvic abscess drainage in Crohn’s disease
2006
Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience
2012
Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas
2011
Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma
2015
Yttrium‐90 radioembolization vs sorafenib for intermediate‐locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis
2014
Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma
2017
Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy.
2007